Literature DB >> 21554783

Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection.

Y J Kim1, S I Kim, Y R Kim, K W Hong, S H Wie, Y J Park, H Jeong, M W Kang.   

Abstract

Carbapenem-resistant Acinetobacter baumannii (CRAB) are an increasing infectious threat in hospitals. We investigated the clinical epidemiology of CRAB infections vs. colonization in patients, and examined the mechanisms of resistance associated with elevated minimum inhibitory concentrations (MICs) for carbapenems. From January to June 2009, 75 CRAB strains were collected. CRAB infection was significantly associated with malignancy and a high APACHE II score. The most dominant resistance mechanism was ISAba1 preceding OXA-51, producing strains with overexpression of efflux pump. Strains carrying blaOXA-23-like enzymes had higher carbapenem MICs than those carrying blaOXA-51-like enzymes; however, the presence of multiple mechanisms did not result in increased resistance to carbapenems. There was no difference in the resistance mechanisms in strains from infected and colonized patients. The majority of strains were genetically diverse by DNA macrorestriction although there was evidence of clonal spread of four clusters of strains in patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554783     DOI: 10.1017/S0950268811000744

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  14 in total

1.  Prevalence of Acinetobacter baumannii strains expressing the Type 6 secretion system in patients with bacteremia.

Authors:  Guillermo D Repizo
Journal:  Virulence       Date:  2017-06-26       Impact factor: 5.882

2.  High Frequency of OXA-253-Producing Acinetobacter baumannii in Different Hospitals in Recife, Brazil.

Authors:  Felipe Lira de Sá Cavalcanti; Carina Lucena Mendes-Marques; Crhisllane Rafaele Dos Santos Vasconcelos; Túlio de Lima Campos; Antonio Mauro Rezende; Danilo Elias Xavier; Nilma Cintra Leal; Osvaldo Pompilio de-Melo-Neto; Marcia Maria Camargo de Morais; Tereza Cristina Leal-Balbino
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

Review 3.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

4.  First detection of OXA-24 carbapenemase-producing Acinetobacter baumannii isolates in Bulgaria.

Authors:  Bozhana Todorova; Tzvetan Velinov; Ivan Ivanov; Elina Dobreva; Todor Kantardjiev
Journal:  World J Microbiol Biotechnol       Date:  2013-11-28       Impact factor: 3.312

5.  Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands.

Authors:  Dae Hun Kim; Ji-Young Choi; Hae Won Kim; So Hyun Kim; Doo Ryeon Chung; Kyong Ran Peck; Visanu Thamlikitkul; Thomas Man-Kit So; Rohani M D Yasin; Po-Ren Hsueh; Celia C Carlos; Li Yang Hsu; Latre Buntaran; M K Lalitha; Jae-Hoon Song; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

6.  Multidrug-Resistant Acinetobacter baumannii Chloramphenicol Resistance Requires an Inner Membrane Permease.

Authors:  Andrew P-A Karalewitz; Samuel I Miller
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

Review 7.  Structural and Functional Diversity of Resistance-Nodulation-Cell Division Transporters.

Authors:  Philip A Klenotic; Mitchell A Moseng; Christopher E Morgan; Edward W Yu
Journal:  Chem Rev       Date:  2020-11-19       Impact factor: 60.622

8.  The impact of inadequate terminal disinfection on an outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit.

Authors:  Wei-Lun Liu; Hsueh-Wen Liang; Mei-Feng Lee; Hsin-Lan Lin; Yu-Hsiu Lin; Chi-Chung Chen; Ping-Chin Chang; Chih-Cheng Lai; Yin-Ching Chuang; Hung-Jen Tang
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

9.  In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam.

Authors:  Vien Le Minh; Nguyen Thi Khanh Nhu; Voong Vinh Phat; Corinne Thompson; Nguyen Phu Huong Lan; Tran Vu Thieu Nga; Pham Thi Thanh Tam; Ha Thanh Tuyen; Tran Do Hoang Nhu; Nguyen Van Hao; Huynh Thi Loan; Lam Minh Yen; Christopher M Parry; Ho Dang Trung Nghia; James I Campbell; Tran Tinh Hien; Louise Thwaites; Guy Thwaites; Nguyen Van Vinh Chau; Stephen Baker
Journal:  J Med Microbiol       Date:  2015-07-17       Impact factor: 2.472

Review 10.  Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.

Authors:  Chang-Ro Lee; Jung Hun Lee; Moonhee Park; Kwang Seung Park; Il Kwon Bae; Young Bae Kim; Chang-Jun Cha; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-03-13       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.